about
Interventions for the reduction of prescribed opioid use in chronic non-cancer painOpioids for neuropathic painOpioids compared to placebo or other treatments for chronic low-back painInterventions for the reduction of prescribed opioid use in chronic non-cancer painOpioids for chronic low-back painOpioids for neuropathic painOpioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.Neuropathic pain: a practical guide for the clinicianLong-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?Opioid prescriptions for chronic pain and overdose: a cohort studyPrevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioidsThe pharmacological basis of opioidsThe Efficacy and Clinical Safety of Various Analgesic Combinations for Post-Operative Pain after Third Molar Surgery: A Systematic Review and Meta-AnalysisMind-body therapies for the self-management of chronic pain symptomsEvidence-based Clinical Practice Guidelines for Interventional Pain Management in Cancer PainOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenRecommendations for the Management of Herpes ZosterThe association of psychedelic use and opioid use disorders among illicit users in the United StatesThe Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A ReviewBrief report: Training internists in shared decision making about chronic opioid treatment for noncancer pain.The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain.Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway.Spinal Compression Fracture Management: A Review of Current Treatment Strategies and Possible Future Avenues.Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence.Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United StatesMorphinofobia: the situation among the general population and health care professionals in North-Eastern PortugalThe analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain.Predictors of long-term opioid use among patients with painful lumbar spine conditionsNo signs of dose escalations of potent opioids prescribed after tibial shaft fractures: a study of Swedish National Registries.Physician introduction to opioids for pain among patients with opioid dependence and depressive symptomsAssociations among pain, non-medical prescription opioid use, and drug overdose history.Relationship of opioid use and dosage levels to fractures in older chronic pain patientsGender differences in risk factors for aberrant prescription opioid useThe effects of opioids and opioid analogs on animal and human endocrine systemsOxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.Pharmacologic management of chronic pain.Impact of pain on health-related quality of life in patients with inflammatory bowel diseaseSubstance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.
P2860
Q24198272-2BC4DC04-A546-4A2D-BF89-675067F060B3Q24200179-310032AB-7F59-4178-855D-B47C248F8EE7Q24200220-2F76F338-3D9C-4581-9C7A-AFD1B30F7E63Q24202027-51A30DE2-CD07-4F26-832B-67F4BED9AE26Q24244092-87B5445E-50FF-410C-9EE4-5402EFCE8DB3Q24245218-72129CAA-0A51-44D0-97C6-D04A1F403974Q24547899-8A368DFC-6644-459E-B72E-F182A9F7A306Q24553796-2333AEE3-DD78-443E-8A5E-55E97B366C04Q24598228-59F326D2-1CED-4B9E-A99A-E853D475F627Q24630037-82FA06D7-2453-4C0B-A694-77624ED7939FQ24812344-35AA512F-A45E-445D-A6E8-629591AE02BFQ26774405-09BB44BA-0AB0-4B89-B8B8-B017C42C49A2Q26860726-A8D2D1AB-A632-4833-BCE1-541B7BF63ABEQ27025190-38AD9EFB-7C12-4779-800C-6D75F18F05EFQ28084722-E9BBF158-650E-48D6-A2C3-32F326DDEE4BQ28209970-4BF14746-6426-48B7-B260-6640AE3E6B5BQ28315869-AA7863F7-3DFB-4CB3-82FB-9354E0295DA2Q28806840-FA939D65-C301-4323-B659-F40E4B03D0E4Q30235088-21339DD9-C4E4-460C-97A5-2869D37C1DC9Q30477491-C7443A70-29E4-4651-968C-E6E492A6358AQ30733453-97221F8D-9CA4-442A-993A-A3C593A9F6C3Q33436392-2EFA5484-D92A-408F-AE68-C1A03E0BED84Q33464011-55FF27DF-2278-486B-B852-AE269CC0C7C8Q33590002-801E1D4A-5525-4EF8-9CDA-B74CABB74E8FQ33602197-0C2412B1-82FD-4F3E-B498-4805D63FEB6EQ33611209-5738D263-419B-4B59-B227-0B1BA4856A21Q33613037-1DFFBB55-9346-4C21-9A1B-CDC3BBB85AD3Q33622522-00E12E8B-3778-4285-96BC-5D91E6FDC295Q33635856-1D82758D-7AF6-4D3E-BA5D-2ECA0E2D590FQ33643478-EAFA194C-CE75-431D-A105-651A42213111Q33667899-067DF1AF-29E0-4DF7-97D1-79C7D2EF4F36Q33724605-886912BD-70CF-4301-821E-436DC58A7672Q33742530-D3FC266F-14A0-47D5-9FF6-7D85BB693CA2Q33761976-5452BC8D-EB33-4BB4-B772-52C26E546962Q33779667-8829B27E-6C44-4AF8-9871-433E8DE9C0F3Q33793250-2FD474FB-DD61-4578-AA02-3EE341644D7CQ33837995-A2AC11D4-5786-4A15-9FEC-236FC2B22700Q33915700-754E99EA-B0E8-4E96-B441-8A4B45A41D9AQ33960394-9EA59A84-C832-40E5-AB81-7FF622D27CE2Q34023153-ECD9F0CD-BEE2-4CB4-B896-36F81DA234EC
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Opioid therapy for chronic pain.
@ast
Opioid therapy for chronic pain.
@en
type
label
Opioid therapy for chronic pain.
@ast
Opioid therapy for chronic pain.
@en
prefLabel
Opioid therapy for chronic pain.
@ast
Opioid therapy for chronic pain.
@en
P356
P1476
Opioid therapy for chronic pain.
@en
P2093
Jianren Mao
P304
P356
10.1056/NEJMRA025411
P407
P577
2003-11-01T00:00:00Z